Unfortunately I have, but what you speak is the PC answer. Very easy and the first thing that would roll off any ones lips. 20% here means 1.8 months. And what are you guarantying about the QOL?
1.8 months of pure wonder? Not the case. So what are you prolonging and at what cost? When is it appropriate to say anything about "time". One week of life extension? One hour? Is 1.8 months the magic number? I thing it is wonderful, but, again, "what's it worth" and who should pay for it.
It's not functional enough to be worth much in my eyes, but if someone wants to pay privately $80,000 for that time - then they should by all means do that. But I wouldn't want the Federal government to pay that out. The value is not there. And, if I had the money, I would pass it on to my family for them to spend and enjoy. Not to be able to sit upright in a bed for 7 more weeks.
It's a marginal improvement at best, being treated like a panacea from many on this board.
Hey I'm long, with a bit of a profit. But I won't hold a large position going forward. There are just too many other novel companies making real demonstrable improvements out there. This company will grind higher, the science is fine, but do not look for a large payout here, and certainly not soon.
That is definitely true, but also accomplished over a very long term - as it should be.
Those wonderful "lifetime" prospects, don't make this issue worth much though - regarding their
important, but very small part in it. Listen, when this came public the euphoria was,
"oh my god" they've got a cure for pancreatic cancer. Simply not true. It's a wonderful cog in the biotech chain with science to move forward with over decades. But there is no magic bullet that they have that will reward shareholders over the next three years.
Not for nothing, but seriously, extending a cancer patients life by two months
isn't really worth squat. Don't mean to sound callous - it's just the stupid truth.
Insurance Co.s won't shell out a ton of dough for that, and even if they did, it would only be for 2 months per
individual. Don't think there is some super cure here, because there is not. Ulrik got this and moved on.
Can't blame him. This won't get an offer for much. Mulroy's desire to go it alone will certainly lead to another
secondary soon. If you have some profits you might want to think about taking them between 10 and 11.
Being driven down by a company preparing to make an offer.
Henchmen at work - as the shares will need to be bought back anyway, by the acquiring company.
So why not knock it from 8 to 5. Then a 10 or 12 dollar offer will look compelling,
saving the acquirer many millions. Why else the utter fall off after the AD,
which, for the most part, was very positive. The stock is acting like that event
portrayed the science and trials as failing. The bid should come pretty quick, because
if it does not, another suitor will jump in and end up costing the current manipulator
millions. It's an amazing game. Stay long and buy more here. It's a gift.